Actively hiring
Machine Learning
Drug Discovery
As featured in
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Hiring now
1
+1 posted in 30 days
Backers
1
Breyer Capital
Momentum
28/100
hiring for its size, in the news
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Precision biomarkers that quantify functional brain change. Supporting drug development and brain health programs.

Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…

AnaBios provides high quality human tissue and cells, including heart, lung and dorsal root ganglia, for drug discovery & academic research.

PostEra uses machine learning for medicinal chemistry, proposing synthesis routes and analogues for drug discovery programmes. Founded in…

Transforming biology from empirical to. Frontier AI lab training the first scientific poly-intelligence to read all the layers of biology…

Earli is a biotechnology company developing a BioAI approach to cancer therapy in which drugs are produced only in the tumor, by the tumor…
News
Network Bio: Building disease-specific AI models with biobank data
Network Bio is uniting academic biobank data to create a large-scale biobank and stratifying the multimodal patient data into digital, disease-specific coh...
Read more
Report
Network Bio Launches With $50 Million Financing And $30+ Million AI Partnership To Build Disease-Specific Models
Network Bio has launched with $50 million in financing to build disease-specific artificial intelligence models trained on large-scale human tissue, blood, molecular and clinical datasets, as the biotechnology company seeks to apply AI to diagnostics, bio
Read more
Report
Network Bio to Build the First Cell-Free RNA Sequence Foundation Model for General Medical Intelligence with NVIDIA
PALO ALTO, Calif., August 19, 2026--Network Bio to Build the First Cell-Free RNA Sequence Foundation Model for General Medical Intelligence with NVIDIA
Read more
Report
Network Bio Launches with $50 Million Financing and World's Largest Patient Tissue Training Dataset - AOL
Read more
Report
Network Bio et NVIDIA collaborent pour concevoir le premier modèle de fondation de séquençage de l'ARN acellulaire dédié à l'intelligence médicale générale
Read more
Report
$50m Network Bio launch & NVIDIA collaboration
Network Bio launched today with $50 million in financing. It has also announced a collaboration with NVIDIA.
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Network Bio over the last 12 months, by layer, with the share of postings for each.
Technologies in use
7
Postings analysed
2
Stack modernity
87/100AI adopter
Languages
Python
Developer tools
Git
AI & ML
LLM
Practices & domains
Machine Learning
AI Agents
CI/CD
Interpretability
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$175k
Typical range
$175k
Open positions
1
1
Jobs
Senior
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 1 | $175k | $175k |
Highest paying role
AI Scientist
$175k
Normalized to USD per year
Growth
Hiring Momentum
24/100
Hiring freeze
Open positions
1
0 opened / 0 closed in 30 days
Median time-to-fill
47 days
faster than 29% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
AI/ML
50% ▲
Sales
50% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Palo Alto
United States
HQ
Palo Alto
1 posted in 90 days
Jobs
$145k – $175k per year • Remote (United States) • 5+ years exp • PhD • Seattle
AI Agents
LLM
Interpretability
Machine Learning
Apply

Breyer Capital 




